Диабет как проблема медицинской профилактики
DOI: https://doi.org/10.29296/25877305-2021-03-02
Номер журнала:
3
Год издания:
2021
Актуальность данной проблемы неинфекционных заболеваний в мире обусловлена ростом
распространенности сахарного диабета (СД), который наряду с ожирением и табакокурением является ведущим
фактором риска неинфекционных заболеваний. В статье приводятся данные, отражающие эпидемиологические,
патофизиологические, диагностические аспекты СД, подробно описаны рекомендации, которые должны быть даны
пациентам врачами первичной медико-санитарной сети. Приведены основные данные, необходимые для управления
этим метаболическим заболеванием.
Ключевые слова:
эндокринология
сахарный диабет
медицинская профилактика
Для цитирования
К.Р. Амлаев Диабет как проблема медицинской профилактики
. Врач, 2021; (3): 9-14 https://doi.org/10.29296/25877305-2021-03-02Список литературы:
- Young B.A., Lin E., Von Korff M. et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008; 14: 15–23.
- da Rocha Fernandes J., Ogurtsova K., Linnenkamp U. et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract. 2016; 117: 48–54. DOI: 10.1016/j.diabres.2016.04.016
- Bhupathiraju S.N., Hu F.B. Epidemiology of obesity and diabetes and their cardio-vascular complications. Circ Res. 2016; 118: 1723–35. DOI: 10.1161/CIRCRESAHA.115.306825
- Boles A.N., Ramesh K., Reddy P.H. Dynamics of diabetes and obesity: Epidemiological perspective. Biochim Biophys Acta Mol Basis Dis. 2017; 1863 (5): 1026–36. DOI: 10.1016/j.bbadis.2017.01.016
- Skyler J.S., Bakris G.L., Bonifacio E. et al. Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis. Diabetes. 2017; 66: 241. DOI: 10.2337/db16-0806
- Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. U.S. Department of Health and Human Services, 2014.
- Zimmet P., Alberti K.G., Magliano D.J. et al. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016; 12: 616–22. DOI: 10.1038/nrendo.2016.105
- Boyle J.P., Thompson T.J., Gregg E.W. et al Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010; 8: 29. DOI: 10.1186/1478-7954-8-29
- Schmidt A.M. Highlighting Diabetes – the Epidemic Continues. Arterioscler Thromb Vasc Biol. 2018; 38 (1): e1–e8. DOI: 10.1161/ATVBAHA.117.310221
- Haak T., Gölz S., Fritsche A. et al. Therapy of Type 1 Diabetes. Exp Clin Endocrinol Diabetes. 2019; 127: S27–S38. DOI: 10.1055/a-0984-5696
- Petersmann A., Müller-Wieland D., Müller U.A. et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2019; 127 (S 01): S1–S7. DOI: 10.1055/a-1018-9078
- Colstrup M., Mathiesen E.R., Damm P. et al. Pregnancy in women with type 1 diabetes: have the goals of St. Vincent declaration been met concerning foetal and neonatal complications? J Matern Fetal Neonatal Med. 2013; 26: 1682–6. DOI: 10.3109/14767058.2013.794214
- Macintosh M.C., Fleming K.M., Bailey J.A. et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006; 333 (7560): 177. DOI: 10.1136/bmj.38856.692986.AE
- Schaefer-Graf U., Napoli A., Nolan C. et al. Diabetes in pregnancy: a new decade of challenges ahead. Diabetologia. 2018; 61 (5): 1012–21. DOI: 10.1007/s00125-018-4545-y
- Lemelman M.B. et al. Neonatal Diabetes Mellitus: An Update on Diagnosis and Management. Clin Perinatol. 2018; 45 (1): 41–59. DOI: 10.1016/j.clp.2017.10.006
- Greeley S.A.W., John P.M., Winn A.N. et al. The Cost-Effectiveness of Personalized Genetic Medicine: The case of genetic testing in neonatal diabetes. Diabetes Care. 2011; 34: 622–7. DOI: 10.2337/dc10-1616
- Triplitt C., Solis-Herrera C., Cersosimo E., et al. Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus. Expert Opin Pharmacother. 2015; 16: 2819–33. DOI: 10.1517/14656566.2015.1114098
- Falciglia M. Causes and consequences of hyperglycemia in critical illness. Curr Opin Clin Nutr Metab Care. 2007; 10: 498–503. DOI: 10.1097/MCO.0b013e3281a3bf0a
- Javeed N., Matveyenko A.V. Circadian Etiology of Type 2 Diabetes Mellitus. Physiology. 2018; 33: 138–50. DOI: 10.1152/physiol.00003.2018
- Landgraf R., Aberle J., Birkenfeld A. et al. Therapy of Type 2 Diabetes. Exp Clin Endocrinol Diabetes. 2019; 127: S73–S92. DOI: 10.1055/a-1018-9106.
- Hämäläinen A.-M., Knip M. Autoimmunity and familial risk of type 1 diabetes. Curr Diab Rep. 2002; 2: 347–53. DOI: 10.1007/s11892-002-0025-2
- Harjutsalo V., Podar T., Tuomilehto J. Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. Diabetes. 2005; 54: 563–9. DOI: 10.2337/diabetes.54.2.563
- Harjutsalo V., Lammi N., Karvonen M. et al. Age at onset of type 1 diabetes in parents and recurrence risk in offspring. Diabetes. 2010; 59: 210–4. DOI: 10.2337/db09-0344
- Agardh E., Allebeck P., Hallqvist J. et al. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011; 40: 804–18. DOI: 10.1093/ije/dyr029
- Alberti K.G.M.M., Eckel R.H., Grundy S.M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120 (16): 1640–5. DOI: 10.1161/CIRCULATIONAHA.109.192644
- Luis M.T.R. LiMa Subclinical Diabetes. Anais da Academia Brasileira de Ciências. 2017; 89 (1 Suppl.): 591–614. DOI: 10.1590/0001-3765201720160394
- Törn C., Mueller P.W., Schlosser M. et al. Diabetes antibody standardization program: Evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia. 2008; 51: 846–52. DOI: 10.1007/s00125-008-0967-2
- Cryer P.E. The barrier of hypoglycemia in diabetes. Diabetes. 2008; 57: 3169–3176. DOI: 10.2337/db08-1084
- American Diabetes Association. Standards of Medical Care in Diabetes – 2017. Diabetes Care. 2017; 40: S4–S5. DOI: 10.2337/dc17-S003
- Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. URL: http://guidelines.diabetes.ca/app_themes/cdacpg/resources/cpg_2013_full_en.pdf
- Ziegler R., Neu A. Diabetes in childhood and adolescence – a guideline-based approach to diagnosis, treatment, and follow-up. Dtsch Arztebl Int. 2018; 115: 146–56. DOI: 10.3238/arztebl.2018.0146
- Самойлова Ю.Г., Ротканк М.А., Жукова Н.Г. и др. Вариабельность гликемии у пациентов с сахарным диабетом 1-го типа: связь с когнитивной дисфункцией и данными магнитно-резонансных методов исследования. Проблемы эндокринологии. 2018; 64 (5): 286–91 [Samoilova I.G., Rotkank M.A., Zhukova N.G. et al. Variability of glycemia in patients with type 1 diabetes mellitus: the relationship with cognitive dysfunction and the results of magnetic resonance imaging. Problems of Endocrinology. 2018; 64 (5): 286–91 (in Russ.)]. DOI: 10.14341/probl9589
- Самойлова Ю.Г., Ротканк М.А., Жукова Н.Г. и др. Маркеры когнитивных нарушений и вариабельность гликемии у пациентов с сахарным диабетом 1-го типа. Журнал неврологии и психиатрии им. C.C. Корсакова. 2018; 118 (4): 48–51 [Samoilova Iu.G., Rotkank M.A., Zhukova N.G. et al. Markers for cognitive impairments and variability of glycaemia in patients with type 1 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2018; 118 (4): 48–51 (in Russ.)]. DOI: 10.17116/jnevro20181184148-51
- Qing C. The molecular biology in wound healing & non-healing wound. Chin J Traumatol. 2017; 20:189–93. DOI: 10.1016/j.cjtee.2017.06.001
- Narayanaswami V., Dwoskin L.P. Obesity: current and potential pharmacotherapeutics and targets. Pharmacol Ther. 2016; 7258: 30194. DOI: 10.1016/j.pharmthera.2016.10.015
- Bendas A., Rothe U., Kiess W. et al.: Trends in incidence rates during 1999–2008 and Prevalence in 2008 of childhood type 1 diabetes in Germany. PLoS One. 2015; 10 (7): e0132716.1. DOI: 10.1371/journal.pone.0132716
- Adolfsson P., Ziegler R., Hanas R. Continuous subcutaneous insulin infusion: special needs for children. Pediatr Diabetes. 2017; 18: 255–61. DOI: 10.1111/pedi.12491
- Cope J.U., Samuels-Reid J.H., Morrison A.E. Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1–12 years. J Diabetes Sci Technol. 2012; 6: 1053–9. DOI: 10.1177/193229681200600509
- Enander R., Gundevall C., Stromgren A. et al. Carbohydrate counting with a bolus calculator improves post-prandial blood glucose levels in children and adolescents with type 1 diabetes using insulin pumps. Pediatr Diabetes. 2012; 13: 545–51. DOI: 10.1111/j.1399-5448.2012.00883.x
- Johnson S.R., Cooper M.N., Jones T.W. et al. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case–control study. Diabetologia. 2013; 56: 2392–400. DOI: 10.1007/s00125-013-3007-9
- Ziegler R., Cavan D.A., Cranston I. et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care. 2013; 36: 3613–9. DOI: 10.2337/dc13-0251
- Bergenstal R.M., Klonoff D.C., Garg S.K. et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013; 369: 224–32. DOI: 10.1056/NEJMoa1303576
- Salas-Salvadó J., Bulló M., Babio N. et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care. 2011; 34: 14–9. DOI: 10.2337/dc10-1288
- Nicola D. Guess Dietary Interventions for the Prevention of Type 2 Diabetes in High-Risk Groups: Current State of Evidence and Future Research Needs. Nutrients. 2018; 10 (9): 1245. DOI: 10.3390/nu10091245 Forouhi N.G., Misra A., Mohan V. et al. Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ. 2018; 361: k2234. DOI: 10.1136/bmj.k2234
- Serra-Majem L., Román-Viñas B., Sanchez-Villegas A. et al. Benefits of the Mediterranean diet: Epidemiological and molecular aspects. Mol Aspects Med. 2019; 67: 1–55. DOI: 10.1016/j.mam.2019.06.001
- Taylor R., Al-Mrabeh A., Sattar N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 2019; 7 (9): 726–36. DOI: 10.1016/S2213-8587(19)30076-2
- Evert A.B., Dennison M., Gardner C.D. et al. Nutrition therapy for adults with diabetes or prediabetes: A consensus report. Diabetes Care. 2019; 42: 731–54. DOI: 10.2337/dci19-0014
- American Diabetes Association. Lifestyle management. Sec. 4. In: Standards of Medical Care in Diabetes – 2017. Diabetes Care. 2017; 40 (Suppl. 1): S33–S43. DOI: 10.2337/dc17-S007
- American Diabetes Association. Obesity management for treatment of type 2 diabetes. Sec. 7. In: Standards of Medical Care in Diabetes – 2017. Diabetes Care. 2017; 40 (Suppl. 1): S57–S63. DOI: 10.2337/dc17-S010
- Lim E.L., Hollingsworth K.G., Aribisala B.S. et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011; 54: 2506–14. DOI: 10.1007/s00125-011-2204-7
- Pan A., Yeli Wang Y., Talaei M. et al. Relation of active, passive, and quit ting smoking with incident diabetes: A meta-analysis and systematic review. Lancet Diabetes Endocrinol. 2015; 3 (12): 958–96. DOI: 10.1016/S2213-8587(15)00316-2
- Елистратов Д.Г. «Тирео-Вит» – секрет долголетия. Медицинская сестра. 2018; 20 (7): 28–32 [Elistratov D.G. Tireo-vit is the secret of longevity. Meditsinskaya Sestra. 2018; 20 (7): 28–32 (in Russ.)]. DOI: 10.29296/25879979-2018-07-06
- Скворцов В.В., Тумаренко А.В., Введенский С.А. и др. Актуальные вопросы диагностики гипертиреоза. Медицинская сестра. 2019; 21 (7): 3–7 [Skvortsov V.V., Tumarenko A.V., Vvedensky S.A. et al. Current issues in the diagnosis of hyperthyroidism. Meditsinskaya Sestra. 2019; 21 (7): 3–7 (in Russ.)]. DOI: 10.29296/25879979-2019-07-01
- Колдова Т., Вербицкая О., Баранова Г. и др. Когнитивные расстройства у коморбидных пациентов с хронической ишемией мозга и гипофункцией щитовидной железы. Врач. 2019; 30 (11): 75–9 [Koldova Т., Verbitskaya O., Baranova G. et al. Cognitive impairment in comorbid patients with chronic brain ischemia and thyroid hypofunction. Vrach. 2019; 30 (11): 75–9 (in Russ.)]. DOI: 10.29296/25877305-2019-11-18
- Sørensen L.E., Jeppesen P.B., Christiansen C.B. Nordic Seaweed and Diabetes Prevention: Exploratory Studies in KK-Ay Mice. Nutrients. 2019; 11 (6): 1435. DOI: 10.3390/nu11061435
- Dugan J.A. Exercise recommendations for patients with type 2 diabetes. JAAPA. 2016; 29: 13–8. DOI: 10.1097/01.JAA.0000475460.77476.f6
- Lange K., Kleine T., Danne T. Initialschulung für Eltern von Kindern mit Diabetes: Aufwand und Effekte bei Kindern und Eltern. Dtsch Med Wochenschr. 2011; 136: 1106–10. DOI: 10.1055/s-0031-1280518
- Lange K., Swift P., Pankowska E. et al. Diabetes education in children and adolescents. Pediatric Diabetes. 2014; 15: 77–85. DOI: 10.1111/pedi.12187
- Martin D., Lange K., Sima A. et al. Recommendations for age-appropriate education of children and adolescents with diabetes and their parents in the European Union. Pediatr Diabetes. 2012; 13 (Suppl. 16): 20–8. DOI: 10.1111/j.1399-5448.2012.00909.x